Schroeder Quoted in SHRM about Biden’s Executive Order to Promote Competition
14 July 2021
Partner Don Schroeder was quoted in a SHRM article titled, “What Does President Biden’s Order on Noncompetes Mean for Employers?,” which covers President Biden’s recently signed executive order that encourages the Federal Trade Commission to ban or limit noncompete agreements in order to promote competition and economic growth.
“Don Schroeder, an attorney with Foley & Lardner in Boston, doesn’t think a wholesale ban on noncompetes is likely, but he does think employers can realistically expect the government to narrow the employment categories for which such agreements can be used,” the article states. “It’s really important for employers to make sure they are aware of the applicable state laws,” Don said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”